Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial

BACKGROUND: Initiation and titration of human regular U-500 insulin (U-500R) with a dosing algorithm of either thrice daily (TID) or twice daily (BID) improved glycemic control with fewer injections in patients with type 2 diabetes treated with high-dose, high-volume U-100 insulin. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabul, Samaneh, Hood, Robert C., Duan, Ran, DeLozier, Amy M., Settles, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045589/
https://www.ncbi.nlm.nih.gov/pubmed/27716283
http://dx.doi.org/10.1186/s12955-016-0541-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045589/
https://www.ncbi.nlm.nih.gov/pubmed/27716283
http://dx.doi.org/10.1186/s12955-016-0541-4

Ejemplares similares